Followers | 2543 |
Posts | 250734 |
Boards Moderated | 34 |
Alias Born | 05/06/2014 |
Monday, July 13, 2020 9:06:26 PM
Recent EQ News
- Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease • Business Wire • 05/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:11:09 PM
- Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights • Business Wire • 05/09/2024 08:01:00 PM
- Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists • Business Wire • 05/07/2024 12:00:00 PM
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/03/2024 12:00:00 PM
- Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis • Business Wire • 04/01/2024 12:00:00 PM
- Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights • Business Wire • 03/25/2024 08:01:00 PM
- Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference • Business Wire • 03/22/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:35:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:01:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:12:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 10:09:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 11:08:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:17:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:14:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:12:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:05:52 PM
- Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease • Business Wire • 12/21/2023 01:00:00 PM
- EQ Bank Card launches in Québec as Carte Banque EQ • PR Newswire (Canada) • 11/20/2023 04:23:00 PM
- EQ Bank Card launches in Québec as Carte Banque EQ • PR Newswire (US) • 11/20/2023 04:23:00 PM
- Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology • Business Wire • 11/13/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:10:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:05:10 PM
- Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates • Business Wire • 11/08/2023 09:01:00 PM
- Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology • Business Wire • 11/06/2023 01:00:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM